NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or momentum characteristics.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | Healthcare | Biotechnology | 6.26% |
| QURE | Uniqure NV | Healthcare | Biotechnology | 5.41% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.99% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 4.53% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 4.50% |
| IDXX | IDEXX Laboratories Inc | Healthcare | Diagnostics & Research | 4.46% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.28% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 4.17% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 4.14% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 4.12% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.10% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.93% |
| DVA | DaVita HealthCare Partners Inc | Healthcare | Medical Care Facilities | 3.86% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.79% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.77% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 3.73% |
| NKTR | Nektar Therapeutics | Healthcare | Biotechnology | 3.71% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.52% |
| MASS | 908 Devices Inc | Healthcare | Medical Devices | 3.44% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.42% |